laboratory animals with negative results, then the epidemiological features of the cases of human exposure to the compound need careful scrutiny.
Investigation ofthe IndividualPatient It is usually difficult and often impossible to determine the cause ofperipheral neuropathy, and there is a regrettable tendency to ascribe it to any substance with which the patient may have been in contact, however slender may be the evidence of toxicity as determined by experiments in animals and use experience.
The widespread and increasing use of pesticides since the 1940s has led to most of them being reported at some time or another as causes of peripheral neuropathy. For most of them, the evidence is both circumstantial and untenable, although there are exceptions to which Dr Fullerton and Dr Barnes have referred.
As an example from my own experience, wood preservation fluids containing several chemical substances, including usually pentachlorophenol, have been reported as causes of peripheral neuropathy. These fluids have been in use for more than thirty years and intensively so for about fifteen. Servicing companies employ men day after day applying fluids of this type in conditions in which, despite carefully planned protective measures, skin contamination and the risk of inhalation of fine droplets are impossible to eliminate completely.
During a ten-year period, one company has employed 1,853 different men working full time on the application ofwood preservation fluids. No case of peripheral neuritis has been reported, although one man with over thirty years' service developed paresthie ofthe fingers which persisted for a short time only.
It has not been possible to obtain a break-down of this group by years of exposure, but the majority remain in this type of work for their whole working life. It is interesting and varied, and, because they work in teams of 2 or 3 scattered widely over the country, they are not subjected to too much supervision from day to day and enjoy the independence which such work ensures. Having seen men at work on wood preservation on a commercial scale, I find it difficult to accept that the cases of peripheral neuritis among persons who have used the fluids for short periods in their homes only are due to absorption of the fluid.
For the individual patient who has peripheral neuritis, every likely cause must be considered but unjustified conclusions should not be drawn.
Prediction ofSusceptibility
It is common practice when reporting cases of peripheral neuropathy, and other conditions which may be due to a toxic agent, for the author to state that no cases from the particular cause have been reported previously and to suggest that his patient may be unusually susceptible to the effects of the substance in question. Recent advances in pharmacogenetics and toxicology have confirmed that there are in most populations individuals who are susceptible to a wide variety of therapeutic and toxic agents which appear not to affect others similarly at risk. Using the modem techniques of genetics it is often possible to demonstrate polymorphism and to devise a suitable test which will enable us to predict susceptibility in an individual. Therefore, before resorting to the blunderbuss cover 'hypersusceptible', we must try to determine whether the individual who has reacted differently to a therapeutic or toxic agent has some abnormality of enzyme or other systems which is genetically determined.
Familiar examples are: (1) G 6 PD-deficiency contributing to sensitivity to primaquine, naphthalene, TNT, aniline or lead, to name but a few.
(2) The slow acetylator who is likely to develop isoniazid neuropathy. (3) The abnormal types of plasma cholinesterase often associated with 210 Proc. roy. Soc. Med. Volume 62 February 1969 The clinical picture of OCP poisoning was distinctive. Were other toxic polyneuropathies also distinctive? Table 1 showed the characteristic features of four types of toxic polyneuropathy which had aroused interest in the last ten years. Dr Paul D Byers (Institute of Orthopedics, London) said that muscle biopsies had been obtained from 8 patients who had been affected during the 1959 Moroccan organophosphorus poisoning disaster. These were an extremely small sample of an estimated 10,000 or more affected people and represented those very few whose limited recovery from the muscle paralysis left them with a marked residual disability. The patients had been seen by Mr Donal Brooks, whose opinion had been sought by the International Red Cross Society and the Moroccan Government. The patients had had a flaccid paralysis of muscles of the lower limb and had later become spastic.
Thirteen muscles were biopsied. The findings in them suggested that denervation and reinnervation of the muscles had occurred. Nothing could be stated about the pathogenesis of the denervation from an examination of the muscles.
